BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19899016)

  • 1. [Vaccinations in recurrent urinary tract infections--an observation study relating to health economy].
    Lenk VS; Dorsch B
    Aktuelle Urol; 2009 Nov; 40(6):360-5. PubMed ID: 19899016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
    Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
    J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections.
    Schaeffer AJ; Stuppy BA
    J Urol; 1999 Jan; 161(1):207-11. PubMed ID: 10037399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women.
    Melekos MD; Asbach HW; Gerharz E; Zarakovitis IE; Weingaertner K; Naber KG
    J Urol; 1997 Mar; 157(3):935-9. PubMed ID: 9072603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.
    Uehling DT; Hopkins WJ; Balish E; Xing Y; Heisey DM
    J Urol; 1997 Jun; 157(6):2049-52. PubMed ID: 9146577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying.
    Sundén F; Håkansson L; Ljunggren E; Wullt B
    J Urol; 2010 Jul; 184(1):179-85. PubMed ID: 20483149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of urinary tract infections with SolcoUrovac].
    Litschgi M
    Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):107-10. PubMed ID: 3106132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections.
    Albrecht U; Goos KH; Schneider B
    Curr Med Res Opin; 2007 Oct; 23(10):2415-22. PubMed ID: 17723159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis.
    Naber KG; Cho YH; Matsumoto T; Schaeffer AJ
    Int J Antimicrob Agents; 2009 Feb; 33(2):111-9. PubMed ID: 18963856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urologic diseases in America project: trends in resource use for urinary tract infections in women.
    Griebling TL
    J Urol; 2005 Apr; 173(4):1281-7. PubMed ID: 15758783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the bacterial vaccine Solco-Urovac® in treatment and prevention of recurrent urinary tract infections of bacterial origin.
    Kochiashvili D; Khuskivadze A; Kochiashvili G; Koberidze G; Kvakhajelidze V
    Georgian Med News; 2014 Jun; (231):11-6. PubMed ID: 25020163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of recurrent urinary infections using Solco Urovac, a polymicrobial vaccine].
    Prát V; Matousovic K; Horcicková M; Hatala M; Milotová Z
    Cas Lek Cesk; 1989 Aug; 128(35):1106-9. PubMed ID: 2605612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bottom-up analysis of the case costs of stem cell transplantation and selected chemotherapies].
    Stäbler W; Wagner B
    Klin Padiatr; 2003; 215(3):179-84. PubMed ID: 12778360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance in children with recurrent or complicated urinary tract infection.
    Younis N; Quol K; Al-Momani T; Al-Awaisheh F; Al-Kayed D
    JNMA J Nepal Med Assoc; 2009; 48(173):14-9. PubMed ID: 19529052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel concentrated cranberry liquid blend, UTI-STAT with Proantinox, might help prevent recurrent urinary tract infections in women.
    Efros M; Bromberg W; Cossu L; Nakeleski E; Katz AE
    Urology; 2010 Oct; 76(4):841-5. PubMed ID: 20399486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.
    Uehling DT; Hopkins WJ; Elkahwaji JE; Schmidt DM; Leverson GE
    J Urol; 2003 Sep; 170(3):867-9. PubMed ID: 12913718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.